One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1158/2159-8290.cd-nb2014-052
Copy DOI
Export
Save
Share
Cite Journal: Cancer Discovery |  Publication Date: Jun 1, 2014 |
 Citations: 2 |
Abstract An advisory panel of the U.S. Food and Drug Administration unanimously recommended approval of Roche's Cobas human papillomavirus DNA test for use as a primary cervical cancer screening tool for women ages 25 and older. If approved, it could be used in lieu of traditional Pap testing.
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
